RAP-103
RAP-103 is an orally active CCR antagonist that effectively protects synapses by inhibiting and reversing cytoskeletal changes induced by PrPC/NOX signaling. RAP-103 is applicable for research in Alzheimer's disease (AD) .
Product Specifications
Molecular Weight
598.61
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AM1384 2 OD, 4 OD, 50 OD
MIRacle™ hsa-miR-5100 miRNA Agomir/Antagomir
Sign In for Pricing
View Details 
MBS7168112 Inquire
Rabbit anti-Saccharomyces cerevisiae (strain YJM789)(Baker's yeast) ATG16 Polyclonal Antibody
Sign In for Pricing
View Details 